Intraventricular Hemorrhage in Children with COVID-19 Confirmed
DOI:
https://doi.org/10.37275/bsm.v6i6.526Keywords:
COVID-19, Intraventricular hemorrhage, Inflammation, LymphocytesAbstract
Background. The most common symptom of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is respiratory symptoms. However, neurological symptoms in adult patients are increasingly being reported. In children, neurological symptoms of COVID-19 are still underreported. This case report was aimed to describe intraventricular hemorrhage in a child with Covid-19 infection.
Case presentation. We report a case of a 15-year-old girl with intraventricular bleeding, which is one of the COVID-19 infection symptoms or a possible symptom of a multisystem inflammatory syndrome in children (MIS-C). Laboratory tests on the first day of treatment showed an increase in leukocytes and decreased lymphocytes. On the 6th day of treatment, the patient had worsening symptoms of consciousness and high fever. The results of laboratory examination showed a decrease in kidney function and an increase in D-dimer.
Conclusion. Severe clinical manifestations of COVID-19 can be in the form of neurological manifestations, one of which is intraventricular hemorrhage.
Authors
- Utari Gustiany G1*
- Rahmi Lestari2
- Finny Fitry Yani3
- 1Department of Pediatrics, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
- 2Neuropediatrics Subdivision, Department of Pediatrics, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
- 3Pediatric Pulmonology Subdivision, Department of Surgery, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
Corresponding author Utari Gustiany G — utari.gustiany.ug@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
